The aXess Pivotal trial is an ongoing research study that will help understand how the new restorative vascular access conduit, aXess, works in patients with end-stage kidney disease that need hemodialysis.
The aXess US Pivotal trial is a prospective, single arm, multi-center study to evaluate the safety and performance of the aXess graft in adult patients with ESRD who need hemodialysis.
140
Patients Enrolling
20
Centers Across US
5
Five Year Patient Follow-up
Information for Patients
Learn more about the aXess Pivotal Trial and the new restorative vascular access conduit.
Patients Study Overview
Information for Professionals
Information for professionals about the aXess Pivotal Trial and the restorative vascular access conduit.
Professional Study Overview
